Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse alpha B Crystallin ELISA Kit (AC3927)
Cat.#: ASET-2516
Specifications
Description Mouse alpha B Crystallin ELISA Kit allows for the in vitro quantitative determination of mouse alpha B Crystallin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1167 Rat NRG1 ELISA Kit (AC2578) Quantitative inquiry ASET-2307 Mouse Neuropilin 1 ELISA Kit (AC3718) Quantitative inquiry ASET-1128 Rat Iba1 ELISA Kit (AC2539) Quantitative inquiry ASET-1008 Human KCNJ4 ELISA Kit (AC2419) Quantitative inquiry ASET-1270 Mouse Asph ELISA Kit (AC2681) Quantitative inquiry ASET-2422 Human SHARP1 ELISA Kit (AC3833) Quantitative inquiry ASET-1935 Human CXCR4 ELISA Kit (AC3346) Quantitative inquiry ASET-1265 Human Syntaxin 4 ELISA Kit (AC2676) Quantitative inquiry ASET-1752 Human Otx2 ELISA Kit (AC3163) Quantitative inquiry ASET-1489 Human PROX1 ELISA Kit (AC2900) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket